LivaNova PLC (LIVN)

Currency in USD
56.37
+0.92(+1.66%)
Closed·
56.370.00(0.00%)
·
LIVN Scorecard
Full Analysis
High shareholder yield
LIVN is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
55.2856.39
52 wk Range
32.4857.35
Key Statistics
Prev. Close
55.45
Open
55.47
Day's Range
55.28-56.39
52 wk Range
32.48-57.35
Volume
472.57K
Average Volume (3m)
657.67K
1-Year Change
11.87%
Book Value / Share
20.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
65.00
Upside
+15.31%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

LivaNova PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

LivaNova PLC Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

LivaNova PLC SWOT Analysis


Medical Tech Frontie
LivaNova leads in cardiopulmonary and neuromodulation, with a $2.28B market cap and potential for growth despite challenges in core markets
Product Innovation
Essenz heart-lung machine drives growth through 2027, while expanded oxygenator capacity and sleep apnea device show promise for market expansion
Financial Outlook
Projected 6-7% organic growth and $3.67 EPS for 2025, with analyst price targets ranging from $55 to $61, suggesting potential undervaluation
Strategic Challenges
Mature markets and legal issues pose risks, but expansion into sleep apnea and depression markets offer new growth avenues for LivaNova
Read full SWOT analysis

LivaNova PLC Earnings Call Summary for Q2/2025

  • LivaNova Q2 2025 EPS of $1.05 beat expectations by 20.69%, revenue of $353M exceeded forecast by 6.11%
  • Stock surged 13.87% pre-market to $48.52 following strong earnings announcement
  • Full-year organic revenue guidance raised to 9-10%, adjusted EPS guidance updated to $3.70-$3.80
  • Company plans rollout of Essence heart-lung machine, pursues CMS coverage for VNS therapy in depression
  • Potential expansion in Chinese market for heart-lung machines signals optimism for future growth
Last Updated: 21/08/2025, 00:42
Read Full Transcript

Compare LIVN to Peers and Sector

Metrics to compare
LIVN
Peers
Sector
Relationship
P/E Ratio
−14.6x21.4x−0.5x
PEG Ratio
0.010.000.00
Price/Book
2.7x2.8x2.6x
Price / LTM Sales
2.4x3.8x3.2x
Upside (Analyst Target)
10.0%62.0%37.1%
Fair Value Upside
Unlock6.6%5.4%Unlock

Analyst Ratings

8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 65.00
(+15.31% Upside)

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
1.05 / 0.87
Revenue / Forecast
352.50M / 332.21M
EPS Revisions
Last 90 days

LIVN Income Statement

People Also Watch

318.65
ELV
+2.65%
475.51
MEDP
+0.54%
67.03
GLW
-2.76%
403.96
HCA
-0.82%
29.04
CNC
+2.33%

FAQ

What Stock Exchange Does LivaNova PLC Trade On?

LivaNova PLC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for LivaNova PLC?

The stock symbol for LivaNova PLC is "LIVN."

What Is the LivaNova PLC Market Cap?

As of today, LivaNova PLC market cap is 3.08B.

What Is LivaNova PLC's Earnings Per Share (TTM)?

The LivaNova PLC EPS (TTM) is -3.89.

When Is the Next LivaNova PLC Earnings Date?

LivaNova PLC will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is LIVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has LivaNova PLC Stock Split?

LivaNova PLC has split 0 times.

How Many Employees Does LivaNova PLC Have?

LivaNova PLC has 2900 employees.

What is the current trading status of LivaNova PLC (LIVN)?

As of 01 Sept 2025, LivaNova PLC (LIVN) is trading at a price of 56.37, with a previous close of 55.45. The stock has fluctuated within a day range of 55.28 to 56.39, while its 52-week range spans from 32.48 to 57.35.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.